H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2024 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory-developed tests; The CONNECT for Health Act, provisions relating to Medicare coverage of telehealth services and limitations on payment for certain laboratory tests; The American Data Privacy and Protection Act (ADPPA), provisions relating to data privacy; Federal policy related to implementation of Section 2213(d) of the Consolidated Appropriations Act, 2023, P.L. 117-328, and Section 18115(a) of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to demographic data reporting obligations for laboratories and reauthorization of the Pandemics and All-Hazards Preparedness Act; S. 866, the American Innovation and Jobs Act, provisions relating to deductibility of research and development expenses for corporate income tax purposes under Internal Revenue Code Section 174; The Right Drug Dose Now Act, provisions relating to adoption of pharmacogenomic testing; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS
531 South Spring Street, Burlington, NC, 27215, US
KATHERINE PREGEL DONALD HORTON